Jianyu Yu
Advisor:
Publications
Yu J, Hao J, Yorek MS, Jiang X, Avellino A, Liu S, Han X, Shilyansky J, Wang Z, Wang Y, Kang Z, Jabbari A, Bing L. FABP5 in skin macrophages mediates saturated fat-induced IL-1β signaling in psoriatic inflammation. Cell Reports. 2025;44(9):116254. doi:https://doi.org/10.1016/j.celrep.2025.116254
Hao J, Jin R, Yi Y, Jiang X, Yu J, Xu Z, Schnicker NJ, Chimenti MS, Sugg SL, Li B. Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Research. 2024;26(1). doi:https://doi.org/10.1186/s13058-024-01873-y
Yu J, Jiaqing H, Yorek MS, Han X, Avellino A, Jiang X, Liu S, Wang J, Li B. Determination of the FABP5 expression profile in skin lesions of an IMQ-induced psoriasis mouse model using flow cytometry. STAR Protocols. 2024;5(2):103018-103018. doi:https://doi.org/10.1016/j.xpro.2024.103018
Hao J, Yu J, Yorek MS, Yu CL, Pope RM, Chimenti MS, Xiong Y, Klingelhutz A, Jabbari A, Li B. Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis. Cell Reports. 2023;42(11):113449-113449. doi:https://doi.org/10.1016/j.celrep.2023.113449
Zhu J, Yu J, Hu A, Liu JQ, Pan X, Xin G, Carson WE, Li Z, Yang Y, Bai XF. IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment. The Journal of Immunology. 2023;211(5):895-902. doi:https://doi.org/10.4049/jimmunol.2300176
Jin R, Hao J, Yu J, Wang P, Sauter ER, Li B. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment. Cancers. 2023; 15(3):657. doi:https://doi.org/10.3390/cancers15030657
Hu A, Zhu J, Zeng C, Lin CH, Yu J, Liu JQ, Lynch K, Talebain F, Pan X, Yan J, Dong Y, Li Z, Bai XF. IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. The Journal of Immunology. 2022;208(9):2239-2245. doi:https://doi.org/10.4049/jimmunol.2100885
Talebian F, Yu J, Lynch K, Liu JQ, Carson WE, Bai XF. CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 2021;9. doi:https://doi.org/10.3389/fcell.2021.739816
Liu JQ, Zhu J, Hu A, Zhang A, Yang C, Yu J, Ghoshal K, Basu S, Bai XF. Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? Am J Cancer Res. 2020 Nov 1;10(11):3565-3574. PMCID: PMC7716159
Liu JQ, Hu A, Zhu J, Yu J, Talebain F, Bai XF. (2020). CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1223. Springer, Cham. doi:https://doi.org/10.1007/978-3-030-35582-1_8
